Literature DB >> 3258550

Inhibitory effect of anti-class II antibodies on human B-cell activation.

Y Tanaka1, F Shirakawa, T Ota, H Suzuki, S Eto, U Yamashita.   

Abstract

The role of class II antigens for B-cell activation was analyzed using purified human B cells and anti-class II monoclonal antibodies. The stimulation of purified B cells with Staphylococcus aureus Cowan I induced proliferation and differentiation into immunoglobulin-producing cells in the presence of interleukin-1 and T-cell-derived factors (B-cell growth factor and B-cell differentiation factor). The addition of anti-class II monoclonal antibodies inhibited B-cell responses. However, anti-class I monoclonal antibody did not inhibit B-cell responses. When mitomycin C and cycloheximide-treated B cells were added to the induction culture of B cells as the stimulator, B-cell responses were enhanced in a dose-dependent manner. Furthermore, the stimulator B cells also partially restored the suppressed B-cell responses which were induced by the pretreatment of B cells with anti-class II antibody. This enhancing effect of stimulator B cells on B-cell responses was inhibited by the pretreatment of stimulator B cells with anti-class II antibody. The treatment of B cells with anti-class II antibody and complement depleted the activity of both responder B cells and stimulator B cells. These results suggest that cellular interaction among B cells exists in the B-cell activation induced with Staphylococcus aureus, Cowan I and anti-class II antibody inhibits B-cell activation by interfering in this cellular interaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258550     DOI: 10.1016/0008-8749(88)90295-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Feedback suppression of B cell colony formation in healthy individuals.

Authors:  L A Fernandez; J M Macsween; D A Robson
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  Idiotypic and anti-idiotypic B-B cell interaction is controlled by major histocompatibility complex-restricted regulation.

Authors:  S Bitoh; S Fujimoto; H Yamamoto
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.